RxDoctor Payments Data

Juan Posada

Hematology & Oncology · Temple, TXNPI 1508827361

Payments from drug & device makers

$665,610in general payments, 2019–2025

Across 196 payments — averaging $3395.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$631K
  • Exelixis Inc.$19K
  • Bristol Myers Squibb$8K
  • Aptevo Therapeutics Inc$7K
  • Johnson & Johnson$245
  • AstraZeneca$98
  • plus $366 from 13 others

What the payments were for

  • Travel & lodging$62837%
  • Food & beverage$1,05263%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$665,610 in reported general payments places this provider in the 80th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas

Other hematology & oncology in Temple

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →